Leveraging approved drugs

dtra-ciproflaxin-liposomes

The Defense Threat Reduction Agency’s (DTRA) Joint Science and Technology Office (JSTO) is working to develop more effective broad-spectrum antibacterials to overcome resistance by developing innovative formulations of approved antibiotics and increasing their efficacy through INFO|MORE 

 

Be the first to comment on "Leveraging approved drugs"

Leave a comment

Your email address will not be published.


*